New drug combo aims to slow diabetic retinopathy
Disease control
Completed
This completed Phase 4 trial tested whether adding a second drug (B55R2) to standard treatment (B55R1) works better for people with non-proliferative diabetic retinopathy, an early stage of diabetic eye disease. 52 adults with mild to severe disease took either the combination or…
Phase: PHASE4 • Sponsor: AJU Pharm Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC